Experimental medicine initiative to explore new therapies (EMINENT)
EMINENT is a collaborative, cross-sector network between the Medical Research Council (MRC), GlaxoSmithKline (GSK) and five UK universities. It allows university researchers work with GSK to access the company’s portfolio of live medicines, in-house drug development and bioinformatics expertise to support research translation.
Find out more about the EMINENT Consortium.
Efficacy and Mechanism Evaluation
The Efficacy and Mechanism Evaluation programme funds clinical trials and similar studies to test the efficacy of innovations to improve patient care. It is co-funded by MRC and National Institute for Health and Care Research. The funding supports translational research of new and repurposed interventions, including:
- diagnostic or prognostic tests and decision-making tools
- therapeutics or psychological treatments and medical devices
- public health initiatives delivered in the NHS
Find out more about Efficacy and Mechanism Evaluation.
MRC-AstraZeneca Centre for Lead Discovery (CLD)
Medical researchers’ investigation of small molecule medicinal drugs can receive support to collaborate with AstraZeneca’s CLD facility at Alderley Park, Cheshire, including access to over 2 million molecules in AstraZeneca’s compound library and their state-of-the-art high-throughput screening facilities.
Read the open funding opportunity Develop new approaches to small molecule medicine.
Horticulture and Potato Initiative (HAPI)
The Horticulture and Potato Initiative connects academic and industrial partners to support the translation of pre-competitive horticultural and potato research.
It is managed by BBSRC and NERC, with Scottish Government and businesses from the fresh produce sector.
Find out more about the Horticulture and Potato Initiative.
UK Aquaculture Initiative
A joint BBSRC and NERC initiative to support innovative research and research translation in developing a healthy, safe and sustainable UK aquaculture system.
Find out more about the UK Aquaculture Initiative.
Researchers in Residence
The EPSRC-funded Innovation Launchpad Network+ brings together cross-functional teams from academia and the Catapults to stimulate the exchange of ideas and knowledge. A key mechanism to achieve the network’s goals is through the delivery of Researchers in Residence (RiR) awards.
These awards are designed to enable academic researchers to work with the Catapults, undertaking a project or activity in an area of strategic importance to collaboratively develop new technologies, tools and techniques. Successful applicants will be awarded up to £50,000 to cover a maximum of six months of university salary costs, travel and accommodation during the placement.
Find out more about Researchers in Residence.
Last updated: 16 August 2023